MCID: CMB089
MIFTS: 20

Combined Hepatocellular Carcinoma and Cholangiocarcinoma

Categories: Cancer diseases, Liver diseases, Rare diseases

Aliases & Classifications for Combined Hepatocellular Carcinoma and Cholangiocarcinoma

MalaCards integrated aliases for Combined Hepatocellular Carcinoma and Cholangiocarcinoma:

Name: Combined Hepatocellular Carcinoma and Cholangiocarcinoma 60
Combined Hepatocellular-Cholangiocarcinoma 60
Hepatocholangiocarcinoma 60
Combined Hcc-Cc 60
Chcc-Cc 60

Classifications:

Orphanet: 60  
Rare hepatic diseases


External Ids:

Orphanet 60 ORPHA529852

Summaries for Combined Hepatocellular Carcinoma and Cholangiocarcinoma

MalaCards based summary : Combined Hepatocellular Carcinoma and Cholangiocarcinoma, also known as combined hepatocellular-cholangiocarcinoma, is related to hepatocellular carcinoma and cholangiocarcinoma. An important gene associated with Combined Hepatocellular Carcinoma and Cholangiocarcinoma is SALL4 (Spalt Like Transcription Factor 4). Affiliated tissues include liver and neutrophil.

Related Diseases for Combined Hepatocellular Carcinoma and Cholangiocarcinoma

Diseases related to Combined Hepatocellular Carcinoma and Cholangiocarcinoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 18)
# Related Disease Score Top Affiliating Genes
1 hepatocellular carcinoma 10.8
2 cholangiocarcinoma 10.8
3 intrahepatic cholangiocarcinoma 10.5
4 hepatitis 10.4
5 cryohydrocytosis 10.3
6 hepatitis b 10.2
7 liver cirrhosis 10.2
8 hepatitis c virus 10.2
9 hepatitis c 10.2
10 hepatoblastoma 10.0
11 tetralogy of fallot 10.0
12 budd-chiari syndrome 10.0
13 dermatomyositis 10.0
14 schistosomiasis 10.0
15 gallbladder cancer 10.0
16 fibrolamellar carcinoma 10.0
17 pulmonary embolism 10.0
18 congenital extrahepatic portosystemic shunt 10.0

Graphical network of the top 20 diseases related to Combined Hepatocellular Carcinoma and Cholangiocarcinoma:



Diseases related to Combined Hepatocellular Carcinoma and Cholangiocarcinoma

Symptoms & Phenotypes for Combined Hepatocellular Carcinoma and Cholangiocarcinoma

Drugs & Therapeutics for Combined Hepatocellular Carcinoma and Cholangiocarcinoma

Search Clinical Trials , NIH Clinical Center for Combined Hepatocellular Carcinoma and Cholangiocarcinoma

Genetic Tests for Combined Hepatocellular Carcinoma and Cholangiocarcinoma

Anatomical Context for Combined Hepatocellular Carcinoma and Cholangiocarcinoma

MalaCards organs/tissues related to Combined Hepatocellular Carcinoma and Cholangiocarcinoma:

42
Liver, Neutrophil

Publications for Combined Hepatocellular Carcinoma and Cholangiocarcinoma

Articles related to Combined Hepatocellular Carcinoma and Cholangiocarcinoma:

(show top 50) (show all 145)
# Title Authors Year
1
A 12-year Recurrence-free Survival After Multidisciplinary Treatment for a Patient With Combined Hepatocellular-Cholangiocarcinoma. ( 30952760 )
2019
2
Prognostic value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with combined hepatocellular-cholangiocarcinoma. ( 31049603 )
2019
3
Malic enzyme 1 is a potential marker of combined hepatocellular-cholangiocarcinoma, subtypes with stem-cell features, intermediate-cell type. ( 31077496 )
2019
4
Imaging of combined hepatocellular-cholangiocarcinoma in cirrhosis and risk of false diagnosis of hepatocellular carcinoma. ( 30788118 )
2019
5
Competing risk analyses of overall survival and cancer-specific survival in patients with combined hepatocellular cholangiocarcinoma after surgery. ( 30813928 )
2019
6
Combined hepatocellular-cholangiocarcinoma: a population level analysis of incidence and mortality trends. ( 30813932 )
2019
7
Radiological features and outcomes of combined hepatocellular-cholangiocarcinoma in patients undergoing surgical resection. ( 30876788 )
2019
8
Combined hepatocellular cholangiocarcinoma (cHCC-CC): an update of genetics, molecular biology, and therapeutic interventions. ( 30643759 )
2019
9
Combined hepatocellular-cholangiocarcinoma with angiosarcomatoid change: A case report with immunohistochemical study. ( 30672653 )
2019
10
Genomic profiling of combined hepatocellular-cholangiocarcinoma reveals similar genetics to hepatocellular carcinoma. ( 30690729 )
2019
11
Combined hepatocellular-cholangiocarcinoma successfully treated with sorafenib: case report and review of the literature. ( 30374884 )
2019
12
Long-term outcomes of combined hepatocellular-cholangiocarcinoma after hepatectomy or liver transplantation: A systematic review and meta-analysis. ( 30442549 )
2019
13
Combined hepatocellular cholangiocarcinoma: LI-RADS v2017 categorisation for differential diagnosis and prognostication on gadoxetic acid-enhanced MR imaging. ( 29955948 )
2019
14
How to utilize LR-M features of the LI-RADS to improve the diagnosis of combined hepatocellular-cholangiocarcinoma on gadoxetate-enhanced MRI? ( 30552477 )
2018
15
Response to Loco-Regional Therapy Predicts Outcomes After Liver Transplantation for Combined Hepatocellular-Cholangiocarcinoma. ( 30600299 )
2018
16
Systemic Therapy for Combined Hepatocellular-Cholangiocarcinoma: A Single-Institution Experience. ( 30323089 )
2018
17
Combined Hepatocellular-Cholangiocarcinoma in a Patient With Cirrhosis Due to Cholesteryl Ester Storage Disease. ( 30372535 )
2018
18
Synchronous cancers of gallbladder carcinoma and combined hepatocellular cholangiocarcinoma: an unusual case and literature review. ( 30373546 )
2018
19
Clinical and pathological features of combined hepatocellular-cholangiocarcinoma compared with other liver cancers. ( 30462849 )
2018
20
Two Surgical Cases of Combined Hepatocellular-Cholangiocarcinoma, Intermediate-Cell Subtype: Potentially Characteristic Gross Features. ( 29967709 )
2018
21
Comparing Clonality Between Components of Combined Hepatocellular Carcinoma and Cholangiocarcinoma by Targeted Sequencing. ( 29976634 )
2018
22
The Predictive Value of Staging Systems and Inflammation Scores for Patients with Combined Hepatocellular Cholangiocarcinoma After Surgical Resection: a Retrospective Study. ( 29667093 )
2018
23
Positive expression of Midkine predicts early recurrence and poor prognosis of initially resectable combined hepatocellular cholangiocarcinoma. ( 29486735 )
2018
24
MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma. ( 29486800 )
2018
25
Clinicopathological features of combined hepatocellular-cholangiocarcinoma with sarcomatous change: Case report and literature review. ( 29504997 )
2018
26
Neutrophil-to-lymphocyte ratio predicts overall survival of patients with combined hepatocellular cholangiocarcinoma. ( 29541193 )
2018
27
A Novel Risk prediction Model for Patients with Combined Hepatocellular-Cholangiocarcinoma. ( 29581782 )
2018
28
Surgical Treatment of Combined Hepatocellular-Cholangiocarcinoma is as Effective in Elderly Patients as it is in Younger Patients: A Propensity Score Matching Analysis. ( 29581790 )
2018
29
Whole-exome mutational and transcriptional landscapes of combined hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma reveal molecular diversity. ( 29408647 )
2018
30
Potential diagnostic performance of contrast-enhanced ultrasound and tumor markers in differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma. ( 29052791 )
2018
31
Imaging features of combined hepatocellular-cholangiocarcinoma on contrast-enhanced ultrasound: correlation with clinicopathological findings. ( 29122222 )
2018
32
Look into hepatic progenitor cell associated trait: Histological heterogeneity of hepatitis B-related combined hepatocellular-cholangiocarcinoma. ( 29270746 )
2017
33
68Ga-PSMA Uptake in Combined Hepatocellular Cholangiocarcinoma With Skeletal Metastases. ( 28806238 )
2017
34
Imaging Features on Contrast-Enhanced Ultrasound and Clinical Characteristics of Hepatitis B Virus-Related Combined Hepatocellular-Cholangiocarcinoma: Comparison with Hepatitis B Virus-Related Hepatocellular Carcinoma. ( 28847498 )
2017
35
Histological heterogeneity in primary and metastatic classic combined hepatocellular-cholangiocarcinoma: a case series. ( 28707055 )
2017
36
Combined Hepatocellular Cholangiocarcinoma (Biphenotypic) Tumors: Potential Role of Contrast-Enhanced Ultrasound in Diagnosis. ( 28777653 )
2017
37
Yttrium-90 Radioembolization for Unresectable Combined Hepatocellular-Cholangiocarcinoma. ( 28432387 )
2017
38
Erratum to: Yttrium-90 Radioembolization for Unresectable Combined Hepatocellular-Cholangiocarcinoma. ( 28534185 )
2017
39
Authors' Reply: Letter to the Editor Regarding "Yttrium-90 Radioembolization for Unresectable Combined Hepatocellular-Cholangiocarcinoma". ( 28550513 )
2017
40
Regarding "Yttrium-90 Radioembolization for Unresectable Combined Hepatocellular-Cholangiocarcinoma". ( 28550514 )
2017
41
Impact of incidental/misdiagnosed intrahepatic cholangiocarcinoma and combined hepatocellular cholangiocarcinoma on the outcomes of liver transplantation: an institutional case series and literature review. ( 28124125 )
2017
42
Influence of cirrhosis on long-term prognosis after surgery in patients with combined hepatocellular-cholangiocarcinoma. ( 28183290 )
2017
43
Living Donor Liver Transplantation for Combined Hepatocellular Carcinoma and Cholangiocarcinoma: Experience of a Single Center. ( 28242867 )
2017
44
Liver transplantation and combined hepatocellular-cholangiocarcinoma: Feasibility and outcomes. ( 28258929 )
2017
45
Clinical features, histology, and histogenesis of combined hepatocellular-cholangiocarcinoma. ( 28293379 )
2017
46
Combined hepatocellular-cholangiocarcinoma: Gadoxetic acid-enhanced MRI findings correlated with pathologic features and prognosis. ( 27875000 )
2017
47
Imaging features predict prognosis of patients with combined hepatocellular-cholangiocarcinoma. ( 27916195 )
2017
48
Mutational landscape of combined hepatocellular carcinoma and cholangiocarcinoma, and its clinicopathological significance. ( 27634656 )
2017
49
Combined hepatocellular-cholangiocarcinoma with stem cell features, cholangiolocellular subtype after inferior vena cava stent placement for a patient with Budd-Chiari syndrome. ( 27900203 )
2016
50
Combined hepatocellular-cholangiocarcinoma in a patient with Abernethy malformation and tetralogy of Fallot: A case report. ( 27227347 )
2016

Variations for Combined Hepatocellular Carcinoma and Cholangiocarcinoma

Expression for Combined Hepatocellular Carcinoma and Cholangiocarcinoma

Search GEO for disease gene expression data for Combined Hepatocellular Carcinoma and Cholangiocarcinoma.

Pathways for Combined Hepatocellular Carcinoma and Cholangiocarcinoma

GO Terms for Combined Hepatocellular Carcinoma and Cholangiocarcinoma

Sources for Combined Hepatocellular Carcinoma and Cholangiocarcinoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....